Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
November 17, 2026 3.060
November 16, 2026 3.060
November 13, 2026 3.060
November 12, 2026 3.060
November 11, 2026 3.058
November 10, 2026 3.058
November 09, 2026 3.049
November 06, 2026 3.053
November 05, 2026 3.036
November 04, 2026 3.044
November 03, 2026 3.049
November 02, 2026 3.042
October 30, 2026 3.047
October 29, 2026 3.040
October 28, 2026 3.034
October 27, 2026 3.027
October 26, 2026 3.025
October 23, 2026 3.027
October 22, 2026 3.027
October 21, 2026 3.027
October 20, 2026 3.029
October 19, 2026 3.027
October 16, 2026 3.029
October 15, 2026 3.029
October 14, 2026 3.025
Date Value
October 13, 2026 3.031
October 12, 2026 3.031
October 09, 2026 3.040
October 08, 2026 3.027
October 07, 2026 3.036
October 06, 2026 3.025
October 05, 2026 3.016
October 02, 2026 3.020
October 01, 2026 3.018
September 30, 2026 3.016
September 29, 2026 3.587
September 28, 2026 3.584
September 25, 2026 3.584
September 24, 2026 3.582
September 23, 2026 3.584
September 22, 2026 3.576
September 21, 2026 3.571
September 18, 2026 3.571
September 17, 2026 3.574
September 16, 2026 3.568
September 15, 2026 3.566
September 14, 2026 3.563
September 11, 2026 3.561
September 10, 2026 3.558
September 09, 2026 3.568

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Viatris, Inc. 1.698
Pacira Biosciences, Inc. 2.043
ANI Pharmaceuticals, Inc. 2.497
Corcept Therapeutics, Inc. 8.883
Veru, Inc. 1.388

Price to Book Value Related Metrics